Marked improvement in bone metabolism parameters after increasing the dialysate calcium concentration from 2.5 to 3mEq/L in nonhypercalcemic hemodialysis patients

Hemodialysis International

Volumn 12, Issue 1, 2008, Pages 73-79

  Vila, Pablo Molina ^a   Sánchez Pérez, Pilar ^a   Garrigós Almerich, Enrique ^a   Peris Domingo, Ana ^a  

^a HOSPITAL FRANCESC DE BORJA   (Spain)

Author keywords

Bone metabolism; Dialysate calcium; Hemodialysis; Secondary hyperparathyroidism

Indexed keywords

ALUMINUM HYDROXIDE; CALCIUM; CALCIUM ACETATE; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; SEVELAMER; VITAMIN D DERIVATIVE;

ADULT; AGED; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DIALYSATE LEVEL; DRUG DOSE REDUCTION; FEMALE; HEMODIALYSIS; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; MALE; OSTEODYSTROPHY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM;

ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; CALCIUM; FEMALE; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PHOSPHORUS; RENAL DIALYSIS;

EID: 39049166041     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00244.x     Document Type: Article

References (27)

1. Cunningham J. Calcium concentration in the dialysate and calcium supplements. Nephrol Dial Transplant. 2000; 15 (Suppl 5): 34-35.
2. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-2218.
3. Slatopolsky E, Weerts C, Lopez-Hilker S, et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Eng J Med. 1986; 315: 157.
4. National Kidney Foundation-Kidney Disease Outcomes Quality Initiative. K/ DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 4 (Suppl 3): S99-s102.
5. Slatopolsky E, Weerts C, Norwood K, et al. Long term effects of calcium carbonate and 2.5 mEq/L calcium dialysate on mineral metabolism. Kidney Int. 1989; 36: 897.
6. Sawyer N, Noonan K, Altmann P, et al. High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: Effective phosphate control and aluminium avoidance in hemodialysis patients. Nephrol Dial Transplant. 1989; 4: 105-109.
7. Van der Merwe W, Rodger R, Grant A, et al. Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in hemodialysis patients. Nephrol Dial Transplant. 1990; 5: 874-877.
8. Fernández E, Borràs M, Pals B, et al. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol. 1995; 6: 132-135.
9. Argilés A, Mourad G. How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism? Nephrol Dial Transplant. 1998; 13 (Suppl 3): 62-64.
10. Locatelli F, Covic A, Chazot C, et al. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant. 2004; 19: 785-796.
11. Van Kuijk WHM, Mulder AW, Peels CH, et al. Influence of changes in ionized calcium on cardiovascular reactivity during haemodialysis. Clin Nephrol. 1997; 47: 190-196.
12. Van der Sande FM, Cheriex EC, Van Kuijk WHM, et al. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis. 1998; 32: 125-131.
13. Nappi SE, Virtanen VK, Saha HH, et al. QTc dispersion increasing during hemodialysis with low-calcium dialysate. Kidney Int. 2000; 57: 2117-2122.
14. Izumi M, Shirai K, Ito K, et al. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines. Ther Apher Dial. 2005; 1: 24-31.
15. Argilés A. Points to remember when selecting dialysate calcium concentration. Nephrol Dial Transplant. 1995; 10: 451-454.
16. Malberti F, Ravani P. The choice of the dialysate calcium concentration in the management of patients on haemodialysis and haemodiafiltration. Nephrol Dial Transplant. 2004; 18 (Suppl 7): 37-40.
17. Toussaint N, Cooney P, Kerr PG. Review of dialysate calcium concentration in hemodialysis. Hemodial Int. 2006; 10: 326-337.
18. Cannata JB, Drueke TB. Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant. 2000; 18 (Suppl 5): 39-57.
19. Arenas MD, Alvarez U de F, Gil MT, et al. Application of NKF-K/DOQI clinical practice guidelines for bone metabolism and disease: Changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant. 2006; 21: 1663-1668.
20. Al Aly Z, González EA, Martin KJ, et al. Achieving K/DOQI laboratory target values for bone and mineral metabolism: An uphill battle. Am J Nephrol. 2004; 24: 422-426.
21. Lorenzo V, Martín-Malo A, Pérez-García R, et al. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: A cross-sectional multicentre study. Nephrol Dial Transplant. 2006; 21: 459-465.
22. Maduell F, Górriz JL, PallardóLM, et al. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia. J Nephrol. 2005; 18: 739-748.
23. Malberti F, Surian M, Minetti L. Dialysate calcium concentration decrease exacerbates secondary hyperparathyroidism in dialysis patients given calcium carbonate as a phosphate binder. J Nephrol. 1991; 2: 75-81.
24. Pedrini LA, De Cristofaro V, Pagliari B, et al. Dialysate/infusate composition and infusion mode in on-line hemodiafitration. Contrib Nephrol. 2002; 137: 344-349.
25. Argiles A, Kerr PG, Canaud B, et al. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int. 1993; 43: 630-640.
26. Martin KJ, Fukagawa M, Malluche HH. Diagnosis of bone and mineral disorders. In: Olgaard K, ed. Clinical Guide to Bone and Mineral Metabolism in Chronic Kidney Disease. 1st ed. New York: National Kidney Foundation; 2006: 45-73.
27. Torregrosa JV, Cannata J, Bover J, et al. Spanish Society of Nephrology recommendations for calcium-phosphorus metabolism. Found at: http://www.senefro.org/modules/subsection/files/ guias_mom.pdf?check_idfile=2871